1. Academic Validation
  2. Triggering of endoplasmic reticulum stress via ATF4-SPHK1 signaling promotes glioblastoma invasion and chemoresistance

Triggering of endoplasmic reticulum stress via ATF4-SPHK1 signaling promotes glioblastoma invasion and chemoresistance

  • Cell Death Dis. 2024 Aug 1;15(8):552. doi: 10.1038/s41419-024-06936-8.
Beiwu Lan 1 2 3 Zhoudao Zhuang 1 2 3 Jinnan Zhang 1 2 3 Yichun He 1 2 3 Nan Wang 1 2 3 Zhuoyue Deng 1 2 3 Lin Mei 1 2 3 Yan Li 4 Yufei Gao 5 6 7
Affiliations

Affiliations

  • 1 Department of Neurosurgery, China-Japan Union Hospital of Jilin University, Changchun, China.
  • 2 Jilin Province Neuro-oncology Engineering Laboratory, Changchun, China.
  • 3 Jilin Provincial Key Laboratory of Neuro-oncology, Changchun, China.
  • 4 Department of Surgery, University of Louisville, Louisville, KY, USA.
  • 5 Department of Neurosurgery, China-Japan Union Hospital of Jilin University, Changchun, China. gaoyf@jlu.edu.cn.
  • 6 Jilin Province Neuro-oncology Engineering Laboratory, Changchun, China. gaoyf@jlu.edu.cn.
  • 7 Jilin Provincial Key Laboratory of Neuro-oncology, Changchun, China. gaoyf@jlu.edu.cn.
Abstract

Despite advances in therapies, glioblastoma (GBM) recurrence is almost inevitable due to the aggressive growth behavior of GBM cells and drug resistance. Temozolomide (TMZ) is the preferred drug for GBM chemotherapy, however, development of TMZ resistance is over 50% cases in GBM patients. To investigate the mechanism of TMZ resistance and invasive characteristics of GBM, analysis of combined RNA-seq and ChIP-seq was performed in GBM cells in response to TMZ treatment. We found that the PERK/eIF2α/ATF4 signaling was significantly upregulated in the GBM cells with TMZ treatment, while blockage of ATF4 effectively inhibited cell migration and invasion. SphK1 expression was transcriptionally upregulated by ATF4 in GBM cells in response to TMZ treatment. Blockage of ATF4-SPHK1 signaling attenuated the cellular and molecular events in terms of invasive characteristics and TMZ resistance. In conclusion, GBM cells acquired chemoresistance in response to TMZ treatment via constant ER stress. ATF4 transcriptionally upregulated SphK1 expression to promote GBM cell aggression and TMZ resistance. The ATF4-SPHK1 signaling in the regulation of the transcription factors of EMT-related genes could be the underlying mechanism contributing to the invasion ability of GBM cells and TMZ resistance. ATF4-SPHK1-targeted therapy could be a potential strategy against TMZ resistance in GBM patients.

Figures
Products